Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare
Aligos Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 2.2M | 3.6M | 6.2M | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -88.0M | -89.2M | -88.1M | -97.6M | -128.3M | -97.8M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -24.2M | -131.2M | -87.7M | -96.0M | -128.3M | -108.5M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 10M | 6M | 3M | 43M | 43M | 38M |
Aligos Therapeutics Inc. Income Statement — FAQ
Aligos Therapeutics Inc. (ALGS) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALGS's income statement history?
The chart and table above show Aligos Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.